Alignment Healthcare: Q3 Earnings Snapshot

Alignment Healthcare Inc. (ALHC) reported a Q3 loss of $8.1 million, matching analyst expectations. Revenue was $1.36 billion, exceeding forecasts. The company expects Q4 revenue of $1.32 billion and full-year revenue of $5.25 billion. Shares have fallen 59% YTD, trading at $8.06 on Thursday.

Original reporting
Published Oct 29, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alignment Healthcare: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$ALHCNeutralMed
01

Why it matters

Revenue outperformance versus Street estimates and forward revenue guidance can influence expectations for top-line growth, but the continued per-share loss signals profitability remains a key risk.

02

Market read

Traders can update models using the reported revenue beat and the stated Q4 and full-year revenue targets, while weighing that EPS remains negative.

03

What to watch

The article lacks medical cost ratio, membership growth, and margin detail; traders may need those to judge whether revenue growth is translating into improving profitability.

Relevance 7/10Novelty 7/10Timing: after-hours/next-session positioning following the Q3 earnings release

Background

Alignment Healthcare is a Medicare Advantage insurer; this report covers Q3 results and provides revenue guidance for the current quarter and full year.

Company-level read

Ticker impact

$ALHCNeutralMedium confidence
Context

Alignment Healthcare reported Q3 revenue of $1.36B, beating forecasts, and guided Q4 revenue to $1.32B while posting a 4-cent EPS loss.

Expected impact

Likely modest upside or stabilization as the revenue beat and guidance offset the ongoing loss.

Evidence & confidence

The article provides fresh quarterly results and forward revenue ranges, but it does not indicate a major surprise versus consensus beyond the revenue beat.

Market effects

Adds datapoint on Medicare Advantage insurer earnings power and guidance credibility, relevant for managed-care peers’ read-through.

Limited, as the company is US-focused and the article provides no regional policy or contract changes.

Low, since this is a single-company US healthcare earnings update.

Counterpoint

The stock’s steep YTD drawdown suggests investors may be discounting structural margin pressure, so a revenue beat may not be enough to reverse sentiment.

Key entities

  • Alignment Healthcare Inc.

    Reported Q3 loss of $8.1M (4 cents per share), revenue of $1.36B, and issued Q4 and full-year revenue guidance.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.